You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 245 No. 2, January 9, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dobutamine Therapy in Acute Myocardial Infarction

Edmund C. H. Keung, MD; Steven J. Siskind, MD; Edmund H. Sonneblick, MD; Hillel S. Ribner, MD; William J. Schwartz, MD; Thierry H. LeJemtel, MD

JAMA. 1981;245(2):144-146.


Abstract

The short-term response of combined dopamine hydrochloride-sodium nitroprusside therapy was compared with administration of dobutamine in eight patients with acute myocardial infarction complicated by hypotension and severe left ventricular dysfunction. All patients were receiving dopamine before the study began. The addition of sodium nitroprusside increased cardiac index (CI) from 1.94±0.49 to 2.22±0.48 L/min/sq m; decreased left ventricular filling pressure (LVFP) from 28.9±3.5 to 19.9±3.3 mm Hg and mean systemic arterial pressure (MAP) from 82.1±5.1 to 71.5±6.0 mm Hg. During dobutamine infusion, CI, LVFP, and MAP were 2.33±0.31 L/min/sq m, 20.8±4.8 mm Hg, and 74.1±8.1 mm Hg, respectively. There was no statistical difference between short-term hemodynamic benefits produced by dobutamine or combined dopamine-sodium nitroprusside therapy. Dobutamine, a synthetic catecholamine, provides a substitute for dopamine-sodium nitroprusside therapy in acute myocardial infarction. Dobutamine has the advantage of being a single agent and is therefore easier to administer.

(JAMA 1981;245:144-146)



Author Affiliations

From the Division of Cardiology, the Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.


Footnotes

Reprint requests to Albert Einstein College of Medicine, Division of Cardiology, 1300 Morris Park Ave, Forchheimer Bldg, Room 715, Bronx, NY 10461 (Dr LeJemtel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dobutamine in Severe Scorpion Envenomation: Effects on Standard Hemodynamics, Right Ventricular Performance, and Tissue Oxygenation
Elatrous et al.
Chest 1999;116:748-753.
ABSTRACT | FULL TEXT  

Cardiogenic Shock
Hollenberg et al.
ANN INTERN MED 1999;131:47-59.
ABSTRACT | FULL TEXT  

Management of Congestive Heart Failure in Patients With Acute Myocardial Infarction
Genton and Jaffe
JAMA 1986;256:2556-2560.
ABSTRACT  

Drugs Five Years Later: Dobutamine
LEIER and UNVERFERTH
ANN INTERN MED 1983;99:490-496.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.